Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat
Lord, R.H.; Hancock, W.W.; Colby, A.J.; Padberg, W.; Diamantstein, T.; Kupiec-Weglinski, J.W.; Tilney, N.L.
Transplantation Proceedings 19(1 Part 1): 354-355
1987
ISSN/ISBN: 0041-1345 PMID: 3079156 Document Number: 288615
Document emailed within 1 workday
Related Documents
Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B. 1988: Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy Transplantation Proceedings 20(2 Suppl 2): 207-216Wang, M.; Qu, X.; Stepkowski, S.M.; Chou, T.C.; Kahan, B.D. 1996: Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus Transplantation 61(3): 458-464
Simmons, J.G.; Hutt-Fletcher, L.M.; Fowler, E.; Feighny, R.J. 1983: Studies of the Epstein-Barr virus receptor found on Raji cells. I. Extraction of receptor and preparation of anti-receptor antibody Journal of Immunology 130(3): 1303-1308
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Cahn, J.Y.; Bordigoni, P.; Tiberghien, P.; Milpied, N.; Brion, A.; Widjenes, J.; Lioure, B.; Michel, G.; Burdach, S.; Kolb, H.J. 1995: Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. a multicenter phase IIi study Transplantation 60(9): 939-942
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Haga, M.; Tsuchida, M.; Hirahara, H.; Watanabe, T.; Hayashi, J.I.; Watanabe, H.; Matsumoto, Y.; Abo, T.; Eguchi, S. 2000: Synergistic effect of anti-T cell receptor monoclonal antibody and 15-deoxyspergualin on cardiac xenograft survival in a mouse-to-rat model Transplantation 69(12): 2613-2621
Hancock, W.W.; Sablinski, T.; Milford, E.L.; Tilney, N.L.; Atkins, R.C.; Kupiec-Weglinski, J.W. 1990: Beneficial effects of monoclonal antibody targeting of CD4+ cells during the sensitisation but not effector phase of accelerated rejection of rat cardiac allografts Transplantation Proceedings 22(5): 2115-2116
Gillies, S.D.; Wesolowski, J.S.; Lo, K.M. 1991: Targeting human cytotoxic T lymphocytes to kill heterologous epidermal growth factor receptor-bearing tumor cells. Tumor-infiltrating lymphocyte/hormone receptor/recombinant antibody Journal of Immunology 146(3): 1067-1071
Xia, J.; Jiang, X.; Huang, Y.; Zhang, K.; Xiao, S.; Yang, C. 2003: Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation Chinese Medical Journal 116(3): 432-435
Spertini, F.ço. 2017: Hope for chronic inflammatory diseases : the anti-IL-6 receptor monoclonal antibody tocilizumab Revue Medicale Suisse 13(544-545): 20-22
Hayes, J.M.; Spencer, W.; Valenzuela, R.; Caulfield, M.; Novick, A.C. 1989: Immunosuppression with an anti-IL-2 receptor monoclonal antibody in a baboon renal allograft model Transplantation Proceedings 21(1 Part 1): 1006-1009
Perussia, B.; Acuto, O.; Terhorst, C.; Faust, J.; Lazarus, R.; Fanning, V.; Trinchieri, G. 1983: Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane Journal of Immunology 130(5): 2142-2148
Wang, Z-hui.; Liao, Y-hua.; Yuan, J.; Zhang, L.; Wang, M.; Zhang, J-hui.; Liu, Z-ping.; Dong, J-hua. 2007: A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy Chinese Medical Journal 120(15): 1319-1325
Chrétien, I.; Helm, B.A.; Marsh, P.J.; Padlan, E.A.; Wijdenes, J.; Banchereau, J. 1988: A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23) Journal of Immunology 141(9): 3128-3134
Samelson, L.E.; O'Shea, J.J.; Luong, H.; Ross, P.; Urdahl, K.B.; Klausner, R.D.; Bluestone, J. 1987: T cell antigen receptor phosphorylation induced by an anti-receptor antibody Journal of Immunology 139(8): 2708-2714
Hamawy, M.M.; Oliver, C.; Siraganian, R.P. 1992: Inhibition of IgE binding to RBL-2H3 cells by a monoclonal antibody (BD6) to a surface protein other than the high affinity IgE receptor Journal of Immunology 148(2): 524-531
Schwinzer, R.; Schlitt, H.J.; Wonigeit, K. 1991: Preferential activation of CD45RA+ cells by a monoclonal antibody to the alpha/beta T-cell receptor Transplantation Proceedings 23(1 Part 1): 277-278
Tilney, N.L.; Strom, T.B.; Macpherson, S.G.; Carpenter, C.B. 1974: Populations of infiltrating cells removed from rejecting rat cardiac allografts Surgical Forum 25: 289-292
Osaku, M.; Ueda, M.; Ando, N.; Shinozawa, Y.; Hirota, N.; Shimizu, N.; Abe, O. 1991: Targeted killing of squamous carcinoma cells by a monoclonal antibody-peplomycin conjugate which recognizes the EGF receptor Anticancer Research 11(6): 1951-1956